pubmed-article:70229 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:70229 | lifeskim:mentions | umls-concept:C0227525 | lld:lifeskim |
pubmed-article:70229 | lifeskim:mentions | umls-concept:C0014442 | lld:lifeskim |
pubmed-article:70229 | lifeskim:mentions | umls-concept:C0074473 | lld:lifeskim |
pubmed-article:70229 | lifeskim:mentions | umls-concept:C0243144 | lld:lifeskim |
pubmed-article:70229 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:70229 | pubmed:dateCreated | 1977-10-14 | lld:pubmed |
pubmed-article:70229 | pubmed:abstractText | Monosialoganglioside liposomes are rapidly taken up by the liver as compared to dicetylphosphate, phosphatidic acid or neutral liposomes. Asialoganglioside GM 1 liposomes are taken up with the same avidity as ganglioside GM 1 liposomes. Competition experiments with asialofetuin suggest that this uptake is mediated by specific recognition of the terminal galactose residues of the glyco-lipid liposomes by the receptor present on the plasma membrane of the parenchymal cells of liver. Thus liposomes containing glycolipids with terminal beta-galactosyl residues should provide an approach for specifically directing biologically active molecules to liver parenchymal cells. | lld:pubmed |
pubmed-article:70229 | pubmed:language | eng | lld:pubmed |
pubmed-article:70229 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:70229 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:70229 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:70229 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:70229 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:70229 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:70229 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:70229 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:70229 | pubmed:month | May | lld:pubmed |
pubmed-article:70229 | pubmed:issn | 0006-3002 | lld:pubmed |
pubmed-article:70229 | pubmed:author | pubmed-author:BachhawatB... | lld:pubmed |
pubmed-article:70229 | pubmed:author | pubmed-author:SuroliaAA | lld:pubmed |
pubmed-article:70229 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:70229 | pubmed:day | 26 | lld:pubmed |
pubmed-article:70229 | pubmed:volume | 497 | lld:pubmed |
pubmed-article:70229 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:70229 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:70229 | pubmed:pagination | 760-5 | lld:pubmed |
pubmed-article:70229 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:70229 | pubmed:meshHeading | pubmed-meshheading:70229-An... | lld:pubmed |
pubmed-article:70229 | pubmed:meshHeading | pubmed-meshheading:70229-Li... | lld:pubmed |
pubmed-article:70229 | pubmed:meshHeading | pubmed-meshheading:70229-Ra... | lld:pubmed |
pubmed-article:70229 | pubmed:meshHeading | pubmed-meshheading:70229-Ma... | lld:pubmed |
pubmed-article:70229 | pubmed:meshHeading | pubmed-meshheading:70229-Ki... | lld:pubmed |
pubmed-article:70229 | pubmed:meshHeading | pubmed-meshheading:70229-al... | lld:pubmed |
pubmed-article:70229 | pubmed:meshHeading | pubmed-meshheading:70229-Ga... | lld:pubmed |
pubmed-article:70229 | pubmed:meshHeading | pubmed-meshheading:70229-Pr... | lld:pubmed |
pubmed-article:70229 | pubmed:meshHeading | pubmed-meshheading:70229-Su... | lld:pubmed |
pubmed-article:70229 | pubmed:meshHeading | pubmed-meshheading:70229-Si... | lld:pubmed |
pubmed-article:70229 | pubmed:meshHeading | pubmed-meshheading:70229-Li... | lld:pubmed |
pubmed-article:70229 | pubmed:year | 1977 | lld:pubmed |
pubmed-article:70229 | pubmed:articleTitle | Monosialoganglioside liposome-entrapped enzyme uptake by hepatic cells. | lld:pubmed |
pubmed-article:70229 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:70229 | pubmed:publicationType | In Vitro | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:70229 | lld:pubmed |